Samyang삼양사

Samyang is a loss-making food and chemicals group trading near its 52-week low, with weak domestic demand and a fair-trade cartel probe weighing on sentiment.

Samyang reported trailing twelve-month revenue of ₩2.58T and a small operating profit of ₩113B, but a large net loss of ₩313B, leaving return on equity at -18.6%. Debt is high relative to equity at 127% liabilities-to-equity, with ₩791B of borrowings against ₩631B of cash. The shares closed at ₩42,400, close to the 52-week low of ₩40,750, and are down 17.5% over one year.

What stands out

• Trailing revenue is ₩2.58T, roughly flat with 2025 (₩2.56T), while net income swung from a profit of ₩121B in 2024 to a loss of ₩313B in 2025 and the trailing period.
• Operating margin is steady at about 4.4%, so the net loss is not explained by core operations in the data; the filings provided do not give the cause.
• The stock trades at 0.3 times book value and 0.2 times sales, with a 4.1% dividend yield; P/E is not meaningful because earnings are negative.
• Recent headlines cover a ₩1.4T wheat by-product cartel case where the Fair Trade Commission is moving to sanction Samyang and others, alongside a Japan launch of its Kestose dietary fiber.
• Foreign ownership eased to 4.8% from 5.0% over 60 days, and foreign investors were net sellers over the last 20 days while retail investors were net buyers.

What to watch

• Outcome of the Fair Trade Commission cartel sanctions and the repeated fine disclosures listed in recent filings.
• The debt guarantee decisions for another party filed on 2026-10-23, and any effect on borrowings or contingent liabilities.
• Full-year 2026 results and the reason for the net loss, which the provided data does not explain; the DCF fair value figures in the data vary widely and should not be relied on.